Perimenopause & Menopause Symptoms: A Clinical Guide

Written by Empire Medical Training Editorial Team

Medically reviewed by Betsy Greenleaf, DO Board-Certified OB/GYN & Urogynecologist; Empire Director of Anti-Aging

Updated June 2026 ·11 min read

The years around menopause are one of the most predictable hormonal transitions in human biology, yet they are still widely misunderstood by patients and underappreciated by clinicians. Estrogen, progesterone, and testosterone do not simply switch off — they fluctuate, sometimes wildly, over a span that can stretch across a decade. Those fluctuations drive a recognizable cluster of symptoms that touch nearly every system: the menstrual cycle, the brain, sleep, the genitourinary tract, and bone.

This page is a top-of-funnel, education-first overview written for clinicians and informed patients. It situates the menopause transition within the broader field of hormone replacement therapy and is meant to help you recognize what is happening and when to act. It is clinical education, not medical advice, and nothing here is a treatment recommendation, dosing protocol, or substitute for an evaluation by a qualified provider.

The menopause transition: perimenopause, menopause, postmenopause

It helps to be precise about the vocabulary, because the three terms describe distinct phases with different clinical implications.

Perimenopause is the transition that leads up to menopause. As Empire faculty member Dr. Betsy Greenleaf, DO teaches, perimenopause can begin as early as the mid-thirties and presents with the hallmark signs of hormonal imbalance — irregular periods, heavy or light bleeding, moodiness, night sweats, hot flashes, weight changes, and shifts in libido. A crucial point that is easy to miss: women in perimenopause are still ovulating intermittently, so there remains a real risk of pregnancy, and contraception still needs to be addressed.

Menopause itself is a retrospective diagnosis. It is confirmed only after the cessation of menstrual periods for twelve consecutive months. The implication is more than academic: if a woman goes ten months without bleeding and then bleeds again, the menopause clock restarts. Natural menopause can begin as early as thirty-eight, but the average age falls around fifty to fifty-two.

Postmenopause is the phase that follows. Estrogen settles at a persistently low level, and the longer-term consequences of that low estrogen state — particularly accelerated bone loss and genitourinary changes — come to the foreground.

The hormonal shifts underneath

Sex hormones are far more than reproductive signals. Estrogen and progesterone influence bone density, lipid metabolism, mood, cognition, and cardiovascular health, and they act on receptors throughout the body — uterus, breast, brain, liver, and bone among them. During the menopause transition, ovarian output of estrogen and progesterone declines and becomes erratic. A common and clinically important pattern is high, swinging estrogen paired with low progesterone, which Dr. Greenleaf identifies as the typical hormonal picture of perimenopause. That imbalance — sometimes called relative estrogen dominance — helps explain the heavy, unpredictable bleeding many women experience, because progesterone is what normally stabilizes the uterine lining.

Perimenopause symptoms: the early changes

The earliest and most reliable signal of perimenopause is a change in the menstrual cycle itself. After years of relative regularity, cycles begin to vary — closer together, further apart, heavier, lighter, or skipped. Dr. Greenleaf describes a representative perimenopausal patient as a woman in her late forties with irregular menses that have grown heavier and cloudier over the past year, accompanied by anxiety, irritability, and trouble sleeping. That picture — irregular, heavier bleeding plus mood and sleep disruption — is the classic sign that menopause is approaching.

Early perimenopausal symptoms commonly include:

• Irregular cycles — the hallmark change; periods that lengthen, shorten, or skip.
• Heavy or unpredictable bleeding — driven by high estrogen and low progesterone, and a frequent cause of low ferritin and iron-deficiency from blood loss.
• Night sweats and early hot flashes — vasomotor symptoms can begin well before periods stop.
• Mood changes — anxiety, irritability, and moodiness, reflecting estrogen and progesterone effects on neurotransmitter activity in the brain.
• Sleep disturbance — difficulty falling or staying asleep, sometimes compounded by night sweats.
• Weight changes and shifting libido.

Because perimenopausal cycles are irregular, this stage is also genuinely harder to evaluate with lab testing — an issue discussed further below and covered in depth on our hormone testing and lab panels page.

Menopause symptoms: the full picture

As estrogen declines toward and past the final menstrual period, the symptom set broadens. These are the domains clinicians should be able to recognize and ask about directly, because patients frequently do not connect them to hormones.

Vasomotor symptoms

Hot flashes and night sweats are the signature vasomotor symptoms of menopause and the ones patients most readily name. They reflect the body's destabilized temperature regulation in a low-estrogen state and can range from mildly distracting to severely disruptive, especially at night where they fragment sleep.

Sleep disturbance

Poor sleep is one of the most consequential and most underestimated symptoms. It is partly driven by night sweats, but hormonal shifts affect sleep architecture independently. The downstream effects matter: as Dr. Greenleaf emphasizes in the course, chronically short sleep is itself a metabolic stressor — people sleeping only five to six hours a night carry a substantially higher risk of obesity — so restoring sleep is treated as a clinical priority, not an afterthought.

Mood and cognition

Estrogen and progesterone influence neurotransmitter activity, so falling and fluctuating levels can produce mood swings, anxiety, irritability, and low mood. Many women also report cognitive symptoms — difficulty concentrating and memory lapses often described as “brain fog.” These complaints are real and physiologically grounded, not simply stress.

Genitourinary symptoms

The genitourinary tract is estrogen-dependent, and its tissues thin as estrogen falls. This produces vaginal dryness, painful intercourse, and recurrent bladder and vaginal infections — a cluster Dr. Greenleaf highlights through a patient presenting with exactly these complaints. Unlike hot flashes, which often fade with time, genitourinary symptoms tend to persist or worsen after menopause unless they are treated.

Changes in libido

Declining sex drive is common and multifactorial. Importantly, Dr. Greenleaf cautions that libido is a complicated subject — testosterone and DHEA are not a reliable fix on their own, and patients seeking treatment for low libido do not always get the improvement they expect from simply raising testosterone. The mind-body component is real and deserves attention alongside any hormonal approach.

Bone loss

One of the most important and least visible consequences of menopause is accelerated bone loss. Estrogen is protective of bone, and its decline raises the long-term risk of osteoporosis and fracture. Because this happens silently, it is a central reason the menopause transition warrants proactive medical attention rather than a wait-and-see approach.

How long do symptoms last?

There is no single answer, and honest counseling acknowledges the variability. Perimenopause can last several years, often beginning in the mid-thirties to forties and continuing until menopause is reached around fifty to fifty-two on average. Vasomotor symptoms such as hot flashes commonly persist for several years, and for a meaningful minority of women they continue for a decade or longer.

Two categories behave differently from the rest. Genitourinary symptoms and bone loss are not self-limiting — they tend to persist or progress in the postmenopausal years unless addressed. That distinction matters for how providers frame treatment: some symptoms may be ridden out, but others represent ongoing physiological changes that benefit from intervention.

When to see a provider

Many women assume they simply have to endure these years. They do not. It is reasonable to seek evaluation when symptoms interfere with daily life, sleep, work, relationships, or sexual health — and certain findings warrant prompt attention rather than watchful waiting:

• Heavy, prolonged, or unpredictable bleeding, which can drive iron-deficiency and low ferritin and should be evaluated rather than assumed to be “just perimenopause.”
• Any bleeding after menopause — that is, after twelve months without a period — which always warrants assessment.
• Disruptive hot flashes, night sweats, or insomnia that erode quality of life or function.
• Genitourinary symptoms such as vaginal dryness, pain with intercourse, or recurrent urinary and vaginal infections.
• Mood changes — persistent anxiety, irritability, or low mood — and concerns about bone health, particularly with risk factors for osteoporosis.

One diagnostic caution from Dr. Greenleaf is worth repeating: some clinicians lean on FSH as a stand-alone test for menopause, but the only true diagnosis of menopause is a full year without a period — it cannot be diagnosed by FSH alone. Perimenopausal patients are especially difficult to test because of cycle irregularity, which means clinical judgment, guided by symptoms and cycle timing, drives evaluation more than any single lab value.

Treatment options: an overview

The encouraging part of this conversation is that effective options exist across the spectrum of severity. This is an overview only — specific regimens, dosing, and titration are individualized by a prescriber and taught in clinical training, not prescribed from a web page.

Lifestyle first. Before and alongside any hormonal approach, the foundation is diet, exercise, stress reduction, and sleep. Dr. Greenleaf treats sleep restoration as a concrete clinical target — for example, helping a patient gradually shift bedtime earlier in small increments until they reach a full seven to eight hours — because the metabolic and mood consequences of short sleep compound everything else.

Hormone therapy is the mainstay for moderate-to-severe symptoms, and the approach is matched to the symptom pattern:

• BHRT for women — a practical overview of bioidentical hormone replacement and how providers individualize it for the menopause transition.
• Estrogen replacement therapy — the primary lever for vasomotor and genitourinary symptoms and for bone protection. (See also our overview of low estrogen symptoms.)
• Progesterone therapy — essential for women with a uterus, both to stabilize heavy perimenopausal bleeding and to protect the uterine lining whenever estrogen is given.

A few honest hedges are warranted. Hormone therapy is not appropriate for everyone — there are real contraindications, including hormone-sensitive cancers, a history of blood clots, stroke or heart disease, liver disease, and unexplained vaginal bleeding. The evidence base is also nuanced rather than absolute: large studies such as the Women's Health Initiative showed, for instance, that an estrogen-only arm carried an increased risk of stroke and clots but a decreased risk of breast cancer, colon cancer, and osteoporosis. The clinical takeaway is that benefit and risk must be weighed for the individual patient by a trained provider — which is precisely the judgment that structured education exists to build.

Training for providers

For clinicians, the menopause transition is a high-volume, high-impact area of practice — and one where competent management changes patients' lives. The clinical skill set is specific: distinguishing perimenopause from menopause, recognizing the full symptom picture across vasomotor, sleep, mood, genitourinary, cognitive, and bone domains, interpreting labs in the context of cycle timing, individualizing estrogen and progesterone therapy, and screening contraindications before treating.

Empire Medical Training's curriculum is built around exactly this kind of practical decision-making, taught by board-certified OB/GYN and urogynecologist Dr. Betsy Greenleaf, DO, Empire's Director of Anti-Aging. It connects the science on this page to the hands-on competence required to manage menopausal patients safely and confidently.